CAS 690690-72-3

GPD-1116

Description:

GPD-1116, identified by its CAS number 690690-72-3, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category are often evaluated for their biological activity, including their mechanism of action, efficacy, and safety profile. GPD-1116 may exhibit properties typical of small molecules, such as the ability to interact with specific biological targets, which can lead to desired pharmacological effects. Additionally, its stability, reactivity, and compatibility with various solvents are crucial for its application in drug formulation and development. As with many compounds under investigation, detailed studies are essential to fully understand its characteristics, including any potential side effects or interactions with other substances. Researchers continue to explore its potential in various therapeutic areas, contributing to the broader field of medicinal chemistry.

Formula: C₂₂H₁₆N₄O

Synonyms:

• 1,5-Dihydro-5-phenyl-3-benzyl-4H-pyrazolo[4,3-c][1,8]naphthyridine-4-one
• 4H-Pyrazolo[4,3-c][1,8]naphthyridin-4-one, 1,5-dihydro-5-phenyl-3-(phenylmethyl)-
• GPD-1116
• 3-benzyl-5-phenyl-1H,4H,5H-pyrazolo[4,3-c]1,8-naphthyridin-4-one
• 3-Benzyl-5-phenyl-1H-pyrazolo[4,3-c][1,8]naphthyridine-4(5H)-one

GPD-1116

CAS: 690690-72-3

GPD-1116 is an orally active inhibitor of phosphodiesterase (PDE)4 and PDE1. The compound effectively reduces smoke-induced apoptosis in lung cells. Additionally, GPD-1116 has shown efficacy in various animal disease models, including emphysema, acute lung injury, chronic obstructive pulmonary disease (COPD), asthma, and pulmonary arterial hypertension.

Formula: C₂₂H₁₆N₄O

Color and Shape: Solid

Molecular weight: 352.39

Ref: TM-T201696